These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17316868)

  • 1. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
    Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
    Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
    Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoride exposure impairs glucose tolerance via decreased insulin expression and oxidative stress.
    García-Montalvo EA; Reyes-Pérez H; Del Razo LM
    Toxicology; 2009 Sep; 263(2-3):75-83. PubMed ID: 19540901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea induced beta-cell apoptosis in cultured human islets.
    Maedler K; Carr RD; Bosco D; Zuellig RA; Berney T; Donath MY
    J Clin Endocrinol Metab; 2005 Jan; 90(1):501-6. PubMed ID: 15483097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
    Hu S; Wang S; Dunning BE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1372-9. PubMed ID: 10565863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose recruits K(ATP) channels via non-insulin-containing dense-core granules.
    Yang SN; Wenna ND; Yu J; Yang G; Qiu H; Yu L; Juntti-Berggren L; Köhler M; Berggren PO
    Cell Metab; 2007 Sep; 6(3):217-28. PubMed ID: 17767908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nateglinide and mitiglinide, but not sulfonylureas, induce insulin secretion through a mechanism mediated by calcium release from endoplasmic reticulum.
    Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
    J Pharmacol Exp Ther; 2007 Jul; 322(1):1-7. PubMed ID: 17409272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recording the activity of ATP-sensitive K(+) channels in open-cell cell-attached configuration.
    Tarasov AI
    Methods Mol Biol; 2008; 491():151-64. PubMed ID: 18998091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues.
    Rustenbeck I; Krautheim A; Jörns A; Steinfelder HJ
    Biochem Pharmacol; 2004 May; 67(9):1733-41. PubMed ID: 15081872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ATP-insensitive KATP channels in pancreatic beta-cells underlies a spectrum of diabetic phenotypes.
    Koster JC; Remedi MS; Masia R; Patton B; Tong A; Nichols CG
    Diabetes; 2006 Nov; 55(11):2957-64. PubMed ID: 17065331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
    Ling Z; Wang Q; Stangé G; In't Veld P; Pipeleers D
    Diabetes; 2006 Jan; 55(1):78-85. PubMed ID: 16380479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucose-dependent insulin secretion by insulin: possible role of AMP-activated protein kinase.
    Park SH; Kim SY; Baek WK; Lim B; Park JH; Sung HY; Kim YK; Bae KC; Bae JH; Song DK
    Life Sci; 2009 Jul; 85(3-4):178-83. PubMed ID: 19481554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK; Holst JJ; Vilsbøll T
    IDrugs; 2008 Jul; 11(7):497-501. PubMed ID: 18600596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INGAP-PP up-regulates the expression of genes and proteins related to K+ ATP channels and ameliorates Ca2+ handling in cultured adult rat islets.
    Silva KE; Barbosa HC; Rafacho A; Bosqueiro JR; Stoppiglia LF; Carneiro EM; Borelli MI; Del Zotto H; Gagliardino JJ; Boschero AC
    Regul Pept; 2008 Jun; 148(1-3):39-45. PubMed ID: 18378016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
    McClenaghan NH; Flatt PR; Ball AJ
    J Endocrinol; 2006 Sep; 190(3):889-96. PubMed ID: 17003289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy.
    Sato T; Nishida H; Miyazaki M; Nakaya H
    Diabetes Metab Res Rev; 2006; 22(5):341-7. PubMed ID: 16444778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.